Related Experiment Video
Updated: Nov 16, 2025

Utilizing a Cranial Window to Visualize the Middle Cerebral Artery During Endothelin-1 Induced Middle Cerebral Artery Occlusion
Published on: February 22, 2013
Association between Clinical Characteristics and Laboratory Findings with Outcome of Hospitalized COVID-19 Patients:
Sahar Sobhani1, Reihaneh Aryan2, Elham Kalantari3
1Department of Nursing and Midwifery, Faculty of Nursing, Gonabad University of Medical Sciences, Gonabad, Iran.
Insights
Clinical and laboratory findings in COVID-19 patients predict outcomes. Factors like male sex, age, and elevated inflammatory markers (WBC, CRP) are linked to mortality and ICU admission, aiding in risk stratification.
Area of Science:
- Infectious Diseases
- Clinical Medicine
- Epidemiology
Background:
- Coronavirus disease 2019 (COVID-19) emerged in late 2019 and rapidly became a global pandemic.
- Understanding clinical and laboratory predictors of COVID-19 outcomes is crucial for patient management and early diagnosis.
- Retrospective analysis of hospitalized patients can provide valuable insights into disease progression and mortality factors.
Purpose of the Study:
- To evaluate clinical characteristics and laboratory findings in hospitalized COVID-19 patients.
- To identify factors associated with mortality, hospitalization duration, and intensive care unit (ICU) admission.
- To explore the potential of these features in risk stratification and developing predictive tools for severe COVID-19 prognosis.
Main Methods:
- Retrospective analysis of medical records from 397 hospitalized COVID-19 patients.
- Data collected between February and May 2020 at Imam Reza Hospital, northeast Iran.
- Comparison of clinical and laboratory features between survivors and non-survivors, and correlation analysis with hospitalization and ICU admission.
Main Results:
- Male sex, older age, longer hospitalization, and ICU admission were significantly associated with higher mortality.
- Headache correlated with survival and shorter hospital stays, while chest pain was linked to longer stays.
- Decreased consciousness and dyspnea were more frequent in non-survivors. Elevated white blood cell (WBC), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) levels were significantly higher in non-survivors and predicted ICU admission.
Conclusions:
- Clinical features like chest pain, decreased consciousness, and dyspnea, along with laboratory markers (WBC, CRP), are potent predictors of severe COVID-19 prognosis.
- These findings can assist clinicians in risk stratifying patients and developing predictive models for better management.
- Early identification of high-risk patients through clinical and laboratory assessment is vital for improving COVID-19 outcomes.
Abstract:
Coronavirus disease 2019 (COVID-19) was first discovered in December 2019 in China and has rapidly spread worldwide. Clinical characteristics, laboratory findings, and their association with the outcome of patients with COVID-19 can be decisive in management and early diagnosis. Data were obtained retrospectively from medical records of 397 hospitalized COVID-19 patients between February and May 2020 in Imam Reza Hospital, northeast Iran. Clinical and laboratory features were evaluated among survivors and nonsurvivors. The correlation between variables and duration of hospitalization and admission to the intensive care unit (ICU) was determined. Male sex, age, hospitalization duration, and admission to ICU were significantly related to mortality rate. Headache was a more common feature in patients who survived (p=0.017). It was also related to a shorter stay in the hospital (p=0.032) as opposed to patients who experienced chest pain (p=0.033). Decreased levels of consciousness and dyspnea were statistically more frequent in nonsurvivors (p=0.003 and p=0.011, respectively). Baseline white blood cell (WBC) count, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) were significantly higher in nonsurvivors (p < 0.001). Patients with higher WBC and CRP levels were more likely to be admitted to ICU (p=0.009 and p=0.001, respectively). Evaluating clinical and laboratory features can help clinicians find ways for risk stratifying patients and even make predictive tools. Chest pain, decreased level of consciousness, dyspnea, and increased CRP and WBC levels seem to be the most potent predictors of severe prognosis.
Related Concept Videos
Pericarditis II: Clinical Features and Diagnostic Tests
Endocarditis II: Clinical Features of Infective Endocarditis
Myocarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

